| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |